Yang W, Waine G J, McManus D P
Molecular Parasitology Unit, Queensland Institute of Medical Research, Royal Brisbane Hospital, Herston, Australia.
Biochem Biophys Res Commun. 1995 Jul 26;212(3):1029-39. doi: 10.1006/bbrc.1995.2073.
Nucleic acid vaccination by intramuscular or intradermal delivery of DNA plasmids encoding antigenic proteins has been shown to confer protection in experimental animals against viruses and unicellular protozoan parasites. However, this revolutionary approach has not been tested for induction of immunity to multicellular parasites, such as trematode worms. We report here, for the first time, that murine antibodies can be induced by intramuscular injection with plasmid DNA encoding fragments of Schistosoma japonicum paramyosin (Sj97), a 97 kDa molecule and a promising vaccine candidate in schistosomiasis. An additional construct containing the gene encoding full-length glutathione S-transferase (Sj26), another recognised anti-schistosome vaccine target, failed to raise detectable levels of specific antibody.
通过肌肉注射或皮内注射编码抗原蛋白的DNA质粒进行核酸疫苗接种,已被证明可在实验动物中提供针对病毒和单细胞原生动物寄生虫的保护。然而,这种革命性的方法尚未针对诱导对多细胞寄生虫(如吸虫)的免疫进行测试。我们在此首次报告,通过肌肉注射编码日本血吸虫副肌球蛋白(Sj97)片段的质粒DNA可诱导小鼠产生抗体,Sj97是一种97 kDa的分子,也是血吸虫病中有前景的疫苗候选物。另一个包含编码全长谷胱甘肽S-转移酶(Sj26)基因的构建体,Sj26是另一个公认的抗血吸虫疫苗靶点,未能产生可检测水平的特异性抗体。